You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科美診斷(688468.SH):收到2項發明證書
格隆匯 06-14 16:13

格隆匯6月14日丨科美診斷(688468.SH)公佈,公司及全資子公司上海索昕生物科技有限公司於近日收到了2項國家知識產權局頒發的發明證書。

用於光激化學發光檢測的感光微球專利(ZL202310106610.9),涉及一種用於光激化學發光檢測的感光微球,將該感光微球與發光微球進行混合反應,可以使發光微球的化學發光信號的強度滿足在光激化學發光檢測中的需求,減少化學發光信號受到其他干擾因素的影響所導致的檢測結果的波動,使檢測結果在臨牀應用中具有一致性和可重複性,且使檢測結果具有更明確的區分度和較高的精密性。本次申請的感光微球,通過明確的數值限定,給出了感光微球應用於光激化學檢測中可供執行的性能標準,具有明確的可操作性,適用於行業規範的推廣。

耗材餘量更新方法、裝置、電子設備及存儲介質(ZL202011631541.6),涉及全自動化學發光免疫分析儀上的耗材管理,例如反應杯、Tip等耗材的管理。使用本專利技術的全自動化學發光免疫分析儀,可以提高耗材管理的效率,避免耗材管理中的誤操作,精確實現耗材的必要管理,從而提高測試任務的管理效率,改善用户友好度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account